NCT00796549 - BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

May 31, 2012

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

BiBW 2992

BIBW 2992 in EGFR FISH positive NSCLC patients

Trial Locations (13)

1200.40.39011 Boehringer Ingelheim Investigational Site, Arezzo

1200.40.39007 Boehringer Ingelheim Investigational Site, Aviano (PN)

1200.40.39013 Boehringer Ingelheim Investigational Site, Faenza (RA)

1200.40.39003 Boehringer Ingelheim Investigational Site, Genova

1200.40.39010 Boehringer Ingelheim Investigational Site, Livorno

1200.40.39012 Boehringer Ingelheim Investigational Site, Lugo (RA)

1200.40.39008 Boehringer Ingelheim Investigational Site, Modena

1200.40.39005 Boehringer Ingelheim Investigational Site, Monza (MI)

1200.40.39006 Boehringer Ingelheim Investigational Site, Padua

1200.40.39002 Boehringer Ingelheim Investigational Site, Perugia

1200.40.39004 Boehringer Ingelheim Investigational Site, Prato

1200.40.39009 Boehringer Ingelheim Investigational Site, Ravenna

1200.40.39001 Boehringer Ingelheim Investigational Site, Rozzano (MI)